{"id":38366,"date":"2010-10-27T12:01:40","date_gmt":"2010-10-27T11:01:40","guid":{"rendered":"https:\/\/copleyv3.fifteen.dev\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/"},"modified":"2010-10-27T12:01:40","modified_gmt":"2010-10-27T11:01:40","slug":"abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar","status":"publish","type":"post","link":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/","title":{"rendered":"Abbreviated impactor testing on programme at dry powder inhaler seminar"},"content":{"rendered":"<div class=\"entry-content\"><p><span style=\"text-decoration: underline;\"><strong>27 October 2010; Nottingham, UK<\/strong><\/span>: As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers. The seminar on 8 November 2010 precedes the annual Management Forum conference on Inhaled Drug delivery, an international event that takes place 8\u2010\u00a09 November at Le Meridien Hotel, Piccadilly, London, UK.<\/p>\n<p>APSD measurement is mandated by the regulators for all inhaled products, because of the influence of particle size on in vivo behaviour. Abbreviated impactor testing, as the name suggests, cuts the time taken to access defining size parameters. Mark Copley will explore the potential of abbreviated impactor measurements and efficient data analysis, to streamline and accelerate testing during development and QC and, more generally, consider developments towards better in vitro\/in vivo correlation.<\/p>\n<p>For more details about the Management Forum seminar go to\u00a0\u00a0 <a href=\"http:\/\/www.management\u2010forum.co.uk\/pharmaceutical\/eventid\/1410\">http:\/\/www.management\u2010forum.co.uk\/pharmaceutical\/eventid\/1410<\/a><\/p>\n<p>For details of Copley Scientific\u2019s solutions for inhaler testing visit <a href=\"http:\/\/www.copleyscientific.com\">www.copleyscientific.com<\/a><\/p>\n<p style=\"text-align: center;\">\n<h3><strong>About Copley Scientific<\/strong><\/h3>\n<p>Copley Scientific is recognised as the world\u2019s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company is also active in detergent testing, air sampling and aerosol characterisation.<\/p>\n<p>Copley Scientific\u2019s pharmaceutical product range includes test equipment for: delivered dose uniformity and aerodynamic particle size measurement of metered\u2010dose inhalers, dry powder inhalers, nebulizers and nasal sprays; as well as tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories and transdermals.<\/p>\n<p>Copley Scientific has offices in the UK and Switzerland. The company works in partnership with aerosol particle science experts MSP Corporation in North America, and also distributes MSP Corporation\u2019s air sampling and aerosol characterisation products throughout Europe.<\/p>\n<p>Serving the pharmaceutical and associated industries, Copley Scientific offers an extensive range of equipment for research, development and quality control, as well as full validation and aftersales services. This broad range of products is supplied and supported worldwide through a network of specialist distributors. <a href=\"http:\/\/www.copleyscientific.com\">www.copleyscientific.com\u00a0\u00a0<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"27 October 2010; Nottingham, UK: As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers. The seminar on 8 November 2010 precedes the annual Management&#8230; <br><a class=\"view-article\" href=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/\">View Article<\/a>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[200],"tags":[],"class_list":["post-38366","post","type-post","status-publish","format-standard","hentry","category-200"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abbreviated impactor testing on programme at dry powder inhaler seminar - Copley Scientific<\/title>\n<meta name=\"description\" content=\"As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abbreviated impactor testing on programme at dry powder inhaler seminar - Copley Scientific\" \/>\n<meta property=\"og:description\" content=\"As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/\" \/>\n<meta property=\"og:site_name\" content=\"Copley Scientific\" \/>\n<meta property=\"article:published_time\" content=\"2010-10-27T11:01:40+00:00\" \/>\n<meta name=\"author\" content=\"fifteen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"fifteen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abbreviated impactor testing on programme at dry powder inhaler seminar - Copley Scientific","description":"As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/","og_locale":"zh_CN","og_type":"article","og_title":"Abbreviated impactor testing on programme at dry powder inhaler seminar - Copley Scientific","og_description":"As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers.","og_url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/","og_site_name":"Copley Scientific","article_published_time":"2010-10-27T11:01:40+00:00","author":"fifteen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"fifteen","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/#article","isPartOf":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/"},"author":{"name":"fifteen","@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c"},"headline":"Abbreviated impactor testing on programme at dry powder inhaler seminar","datePublished":"2010-10-27T11:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/"},"wordCount":360,"articleSection":["\u5438\u5165\u5236\u5242\u8bd5\u9a8c"],"inLanguage":"zh-CN"},{"@type":"WebPage","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/","url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/","name":"Abbreviated impactor testing on programme at dry powder inhaler seminar - Copley Scientific","isPartOf":{"@id":"https:\/\/www.copleyscientific.com\/#website"},"datePublished":"2010-10-27T11:01:40+00:00","author":{"@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c"},"description":"As part of a panel of speakers, Mark Copley, Sales Director for Copley Scientific, will discuss \u2018APSD [aerodynamic particle size distribution] and abbreviated impactor testing\u2019 at a one\u2010day seminar focusing on the experiences and challenges of developing dry powder inhalers.","breadcrumb":{"@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/abbreviated-impactor-testing-on-programme-at-dry-powder-inhaler-seminar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.copleyscientific.com\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"Abbreviated impactor testing on programme at dry powder inhaler seminar"}]},{"@type":"WebSite","@id":"https:\/\/www.copleyscientific.com\/#website","url":"https:\/\/www.copleyscientific.com\/","name":"Copley Scientific","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.copleyscientific.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Person","@id":"https:\/\/www.copleyscientific.com\/#\/schema\/person\/91b846caa5fc98ce157439466ff2600c","name":"fifteen","image":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/90a7aefe9a61edd78fd2f3a689184af548768d9da2fd48656f39a6b7b575a237?s=96&d=mm&r=g","caption":"fifteen"},"sameAs":["http:\/\/localhost:8888\/copley-v3"],"url":"https:\/\/www.copleyscientific.com\/zh-hans\/news-events\/author\/fifteen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts\/38366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=38366"}],"version-history":[{"count":0,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/posts\/38366\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=38366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=38366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.copleyscientific.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=38366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}